Dr. Joshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20055 Lake Chabot Rd
Ste 130
Castro Valley, CA 94546Phone+1 510-888-0657Fax+1 510-886-4532
Education & Training
Seton Hall University-Hackensack Meridian School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2006
Government Medical College GujuratClass of 1999
Certifications & Licensure
CA State Medical License 2005 - 2025
NJ State Medical License 2007 - 2011
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Publications & Presentations
PubMed
- 2 citationsInduction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.Jacqueline V Aredo, Heather A Wakelee, Angela Bik-Yu Hui, Sukhmani K Padda, Nitin D Joshi
Cancer Treatment and Research Communications. 2022-01-01 - 4 citationsPD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature ReviewMaggie Zhou, Nitin Joshi, Kavitha P. Raj, Heather A. Wakelee, Joel W. Neal
Clinical Lung Cancer. 2021-05-01 - 7 citationsPharmacokinetic characteristics of fentanyl iontophoretic trandermal system over a range of applied current.J Brad Phipps, Nitin Joshi, Kelly A Regal, Jinfang Li, Raymond S. Sinatra
Expert Opinion on Drug Metabolism & Toxicology. 2015-03-12
Press Mentions
Newly Developed Nasal Spray and Vaccine Could Contain Respiratory Disease PathogensSeptember 30th, 2024- Why the World Still Needs Innovative COVID-19 Solutions Beyond VaccinesApril 27th, 2021
- Nanoparticle Drug-Delivery System Developed to Treat Brain DisordersJanuary 4th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
